WASHINGTON — Senior administration officials are promising that Friday afternoon, President Trump will roll out “the most comprehensive plan to tackle prescription drug affordability of any president.”

But ahead of his 2 p.m. remarks, the White House is keeping the actual plans under wraps — only hinting at the kinds of new policies that might come out in a “blueprint,” to be released alongside the speech and entitled “American Patients First.” In a late Thursday call with reporters, two senior administration officials largely deflected questions about exactly what’s to come in that blueprint, or in a separate “request for information” — an early regulatory outline of proposals — that will also accompany the remarks.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy